2 November 2019 - Under a new bill, a handful of new drugs might never get produced. That would be worth it.

A bill now making its way through the House could finally provide relief from the sky-high drug prices that have become a hallmark of the American health care industry. But to get there, Americans will need to accept a trade-off that other advanced nations have long since come around to: 

Slightly fewer new drugs will come to market, in exchange for better prices on the medications that already exist.

Read New York Times Editorial